Home
OPKO Health, Inc.

OPKO Health, Inc. Market Share Analysis for May 2026

OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".

Health > Biotechnology and Pharmaceuticals

Domainopko.com

Year Founded2007

Employees1001 - 5000

Annual Revenue> $1B

OPKO Health, Inc.

OPKO Health, Inc. (including company regionals)

opko.com

See more website traffic and engagement information

OPKO Health, Inc. Revenue up to May 2026 is > 1B

revenue generated by OPKO Health, Inc. top domains

OPKO Health, Inc. top domains revenue over 3 years

Revenue for OPKO Health, Inc. top domains

opko.com> 1B

See more with Sales Intelligence

Total visits to OPKO Health, Inc.'s top domains

Understand OPKO Health, Inc. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

opko.com7.7K

See more with Sales Intelligence

Avg. visit duration in OPKO Health, Inc.'s top domains

Analyze OPKO Health, Inc. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

opko.com00:00:23

See more with Sales Intelligence

Avg. pageviews on OPKO Health, Inc.'s top domains

See how OPKO Health, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

opko.com1.71

See more with Sales Intelligence

OPKO Health, Inc. top competitors by domain

Top similar sites in May 2026, ranked by their affinity

bioreference.comCompany NameBioReferenceEmployees1001 - 5000HQUnited States, New Jersey, Elmwood ParkAnnual revenue$500M - $1BTotal visits89.7KHealth > Health - Other

Top technologies used by OPKO Health, Inc.

These are the website technologies, by industry, used by OPKO Health, Inc. top domains

Payment & Currencies (7)

Cart Functionality

Widget (4)

Twemoji

Audio Video Media (2)

YouTube

Conversion & Analytics (2)

Google Analytics

More Technologies

10

See all

News & Signals from OPKO Health, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsOPKO Health Inc. is developing tetraspecific antibody for treatment of B-cell lymphomas.OPKO Health's ModeX Therapeutics begins clinical trial of tetraspecific antibody for treatment of B-cell lymphomas.

NewsOPKO Health Inc. hired Subbarao V. Uppaluri as independent director on Mar 18th '26.OPKO Health appointed Subbarao V. Uppaluri, Ph.D. as a new independent director effective March 18, 2026.

NewsOPKO Health Inc. attended event Piper Sandler 37th Annual Healthcare Conference on Nov 19th '25.MIAMI, Nov. 19, 2025 (GLOBE NEWSWIRE) - OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the Piper Sandler 37th Annual Healthcare Conference, being held December 2-4, 2025 at the Lotte New York Palace Hotel in New York City.